col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt

Verlag: Thomson Reuters (Prous Science)

19 Ergebisse       Seite 1

 [1] 
  Original Artikel Journal Datum Titel Autoren Alle Autoren
1 [GO] Drugs of Today 2023―Mai―18 Development of subunit vaccines against severe acute respiratory syndrome L. Du, Y. He, S. Jiang, B.-J. Zheng
2 [GO] Drugs of Today 2023―Feb―27 Anakinra as a potential treatment for COVID-19
3 [GO] Drugs of Today 2022―Dez―16 COVID-19 vaccination in patients with multiple sclerosis receiving disease-modifying therapies: pragmatic issues I.-A. Chirap-Mitulschi, C. Ghimus, A.R. Chirap-Mitulschi, S.A. Antoniu, R. Dragomir
4 [GO] Drugs of Today 2022―Dez―16 New product intros [deucravacitinib (first-in-class); eflapegrastim; ensitrelvir; monovalent, recombinant-protein next-generation COVID-19 vaccine, adjuvanted using GSK's pandemic adjuvant; tozinameran/famtozinameran]
5 [GO] Drugs of the Future 2022―Dez―15 Lenzilumab. Anti-GM-CSF monoclonal antibody, Treatment of chronic myelomonocytic leukemia, Treatment of COVID-19 A.M. Kalaiger, M. Assi, Z . Temesgen
6 [GO] Drugs of the Future 2022―Nov―15 An overview of prophylaxis and treatment indications for COVID-19-related thrombotic complications. Review of the recent literature A. Moreno-Castaño, G. Escolar, M. Diaz-Ricart
7 [GO] Drugs of Today 2022―Nov―09 New product intros (finasteride/tadalafil (new combination); sutimlimab; human SARS-CoV-2 recombinant nanoparticle vaccine, adjuvanted with AS03; bupropion hydrochloride/dextromethorphan hydrobromide (new combination))
8 [GO] Drugs of Today 2022―Jul―08 Molnupiravir for the treatment of COVID-19 B.G. Santani, B.W. LeBlanc, R.P. Thakare
9 [GO] Drugs of Today 2022―Mai―06 Fluticasone propionate as a potential treatment for COVID-19 M.W. McCarthy
10 [GO] Drugs of Today 2022―Mai―06 New product intros [ansuvimab; benzoyl peroxide/tretinoin (new combination); faricimab; gallium (68Ga) gozetotide, kit for preparation; leuprolide mesylate; lutetium (177Lu) vipivotide tetraxetan; SARS-CoV-2 recombinant spike protein nanoparticle vaccine]
11 [GO] Drugs of the Future 2021―Dez―13 Molnupiravir. RNA-directed RNA polymerase (RdRp) inhibitor, Treatment of mild to moderate COVID-19 G. Kaul, A. Dasgupta, S. Chopra
12 [GO] Drugs of the Future 2021―Okt―22 Repurposing approach of fluvoxamine for COVID-19 M.W. McCarthy
13 [GO] Drugs of the Future 2021―Sep―22 Investigational antiviral drugs for the treatment of COVID-19 C.T.R. Vegivinti, M. Assi, R. Talwani, V. Koblizek, K. Burke, Z. Temesgen
14 [GO] Drugs of the Future 2021―Sep―22 Investigational immunomodulatory therapies for COVID-19 M. Assi, K.M. Koshy, W. El Atrouni, K. Burke, M. Berg, A. Opardija, Z. Temesgen
15 [GO] Drugs of Today 2021―Apr―07 New product intros [Ad5-nCoV, COVID-19 inactivated vaccine (WIV04 strain), Ebola virus vaccine (rVSV-EBOV, live), JNJ-78436735, lonafarnib, margetuximab, romiplostim (new indication), tenapanor (first-in-class), tirbanibulin, tocilizumab (new indication), trilaciclib hydrochloride, ZF-2001] A. Babu
16 [GO] Drugs of Today 2021―Mrz―05 New product intros [berotralstat hydrochloride, cetuximab sarotalocan, daratumumab sc (new indication), eptacog beta, coagulation factor VIIa-jncw, etesevimab, evinacumab-dgnb (first-in-class), human SARS-CoV-2 inactivated vaccine, inclisiran, orelabrutinib, relugolix (new indication), remogliflozin etabonate/vildagliptin (new combination), surufatinib, voclosporin]
17 [GO] Drugs of Today 2021―Feb―15 New product intros [anakinra (new indication), bamlanivimab, baricitinib (new indication), BBIBP-CorV, belimumab (new indication), calcium oxybate/magnesium oxybate/potassium oxybate/sodium oxybate (new formulation), casirivimab/imdevimab, ensartinib hydrochloride, favipiravir (new indication), Gam-COVID-Vac, inactivated SARS-CoV-2 vaccine, loteprednol etabonate (new indication), lumasiran (first-in-class), mRNA-1273, rilonacept (new indication), tozinameran]
18 [GO] Drugs of the Future 2020―Jun―08 Remdesivir. RNA-dependent RNA polymerase inhibitor, Treatment of Ebola virus infection, Treatment of SARS-CoV-2 infection (COVID-19)
19 [GO] Drugs of the Future 2020―Mai―05 Taking aim at a fast-moving target: targets to watch for SARS-CoV-2 and COVID-19 L. Sorbera, A. Graul, C. Dulsat
 [1] 

19 Ergebisse       Seite 1




[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec